about
Ebola: the hidden toll of tuberculosisHow can mathematical models advance tuberculosis control in high HIV prevalence settings?The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical ModellingSex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.HIV and tuberculosis in Ho Chi Minh City, Vietnam, 1997-2002.Modeling of novel diagnostic strategies for active tuberculosis - a systematic review: current practices and recommendations.The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis.Improved retention of patients starting antiretroviral treatment in Karonga District, northern Malawi, 2005-2012.Using the TIME model in Spectrum to estimate tuberculosis-HIV incidence and mortality.Recurrence due to relapse or reinfection with Mycobacterium tuberculosis: a whole-genome sequencing approach in a large, population-based cohort with a high HIV infection prevalence and active follow-upLarge-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area.Food assistance to tuberculosis patients: lessons from AfghanistanIs IPT more effective in high-burden settings? Modelling the effect of tuberculosis incidence on IPT impact.Ability of preventive therapy to cure latent Mycobacterium tuberculosis infection in HIV-infected individuals in high-burden settings.Human immunodeficiency virus associated tuberculosis more often due to recent infection than reactivation of latent infection.The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets.Modelling the social and structural determinants of tuberculosis: opportunities and challenges.Economic evaluation of TB screening programmes in migrants: need for a comprehensive framework.Feasibility of achieving the 2025 WHO global tuberculosis targets in South Africa, China, and India: a combined analysis of 11 mathematical models.Cost-effectiveness and resource implications of aggressive action on tuberculosis in China, India, and South Africa: a combined analysis of nine models.Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.Catastrophic costs potentially averted by tuberculosis control in India and South Africa: a modelling study.Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modellingRe: "Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup".TIME Impact - a new user-friendly tuberculosis (TB) model to inform TB policy decisions.Increased Plasmodium falciparum gametocyte production in mixed infections with P. malariae.Towards elimination in industrialised countries: expanding diagnosis and treatment of LTBI among immigrants.Time for men to count, too.Regarding the effect of cured tuberculosis disease on longevity.To improve our tuberculosis burden estimates we need to learn from each otherEstimating the Impact of Tuberculosis Case Detection in Constrained Health Systems: An Example of Case-Finding in South Africa.Systematic review and analysis of population-based molecular epidemiological studiesCan tuberculosis patients in resource-constrained settings afford chest radiography?What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of TuberculosisThe contribution of asymptomatic SARS-CoV-2 infections to transmission - a model-based analysis of the Diamond Princess outbreakThe potential impact of COVID-19-related disruption on tuberculosis burden
P50
Q24273270-6F37A257-5292-4888-9B87-C736083CE814Q26824057-7D36637D-0126-44B1-91B2-D58831D2D922Q30244104-83F63DA4-458C-476F-BC4E-E105876B2400Q30245603-2E7DBBA2-AD19-4B7C-8C14-782DD426B960Q33776721-595679E2-463F-4CF5-B61A-1FB822605367Q34395434-007C3E49-9415-4BE9-87DF-ABA9D8689A34Q34497528-22EE8AFD-5850-4938-9FFC-34ED2397706EQ34559026-D825344D-9DBF-4D0B-9593-3C2257CB26B3Q34585091-C6309B68-4B43-4A1B-B5D9-773E58FCE0CCQ35163313-C0CD7C23-54EA-4059-A241-3CD61CB44CC4Q35261686-A6E934FC-8EA1-428A-A0BB-2AD1E1E4FDFBQ37020530-6006F091-304A-405E-A9EE-7B7184B24512Q37514147-622D068F-BAEB-4A2B-9202-3C088A67818BQ37702101-57AEB29F-B6DD-4329-B40C-9FB43BDA6A1FQ37833158-17100F14-E0D1-447E-92FC-5601D9DE5FF5Q38246564-BC0BA12F-A1BC-4ED1-9474-59721FBFDA06Q38615933-41A4C2BB-12E0-400F-96D9-D392C1F729DEQ39027414-1BDE6FCB-06DE-4492-8178-06FFEEDCA74BQ39079068-C53D03DC-2A54-4472-8ABB-3C84556F1612Q39245552-0E34C907-2C12-463F-9611-3663C94177A0Q39497926-6B1C58B4-7281-47EF-A80A-4FCDE376F8BCQ42377337-4D8B0AAC-D744-45DA-86B0-0C545EA1A714Q42546968-0684E442-8868-40F1-9CE3-A373EFE143D9Q42782463-1F0D133D-9DE9-4D7C-AF2F-06B875A1A691Q42936293-E7C35BE9-4B07-44A0-938A-FEBC217E1796Q43844755-FCBD6ED5-E935-4D39-936D-9B5BBE76811BQ44808689-96BC4B5E-279D-4A25-8ADB-6222E47D3E07Q46595702-01D8CCAF-F3F1-4FEE-AD04-C43B6E4BA15BQ53808866-71469592-9C0D-4E56-BD93-73F537F9CB59Q58375508-3ACBCFF1-C971-43F7-8020-81ED771046B3Q64913555-439C10F4-4C1E-48B5-809A-65105CA4F78BQ83193255-6E818FFA-297C-4C47-97D2-E6FB465DC00BQ89241822-7E931DCC-1E98-4D69-8B98-E3A6D31D7D6DQ89456938-3DCA03BF-8322-482D-9FC9-8533CB0DFCF3Q95627639-D859AA41-9282-4DB6-9862-98FEAA537665Q96229816-4D79B2D3-CD4D-473D-A3C4-1E3CA6DFFAB9
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Rein M G J Houben
@en
Rein M G J Houben
@nl
type
label
Rein M G J Houben
@en
Rein M G J Houben
@nl
prefLabel
Rein M G J Houben
@en
Rein M G J Houben
@nl
P31
P496
0000-0003-4132-7467